FDA seeks feedback on generative AI regulations

The FDA's initiative to regulate generative AI in healthcare marks a pivotal shift toward formalizing safety standards for autonomous clinical decision-making. Establishing clear oversight is essential to mitigate algorithmic bias and ensure that AI-driven medical devices prioritize patient safety without stifling innovation.